Ray Huang – General Manager, Exponent, Hong Kong
Ray Huang of Silicon Valley consultancy Exponent gives his first impressions of Hong Kong as well as discussing fostering innovation and retaining talent in Asia. Following your recent move…
Company information:
Ming Wai Lau Centre for Reparative Medicine is established to further accelerate research in stem cell biology, biomedical engineering, biotechnology, and regenerative medicine at Karolinska Institutet. By building a front line technology focused hub in Hong Kong, Karolinska Institutet can further strengthen the scientific interactions between KI and the Hong Kong and Chinese scientific communities.
Address: 6F, Building 15W, Hong Kong Science Park, Shatin, New Territories, Hong Kong
Tel.: +852 2624 3807
Website: http://ki.se/en/research/about-ming-wai-lau-centre-for-reparative-medicine
Email: emily.ip@ki.se (Head of Administration)
Ray Huang of Silicon Valley consultancy Exponent gives his first impressions of Hong Kong as well as discussing fostering innovation and retaining talent in Asia. Following your recent move…
Tim Collins of DCH Auriga outlines the Asia-Pacific healthcare distribution landscape, DCH’s expansion plans and what Hong Kong offers as a regional headquarters. After 14 years with LF Asia,…
Ricky Chiu of Phase Scientific International discusses exciting new technological developments in the diagnostic field and the benefits of being based in Hong Kong. Having founded PHASE Scientific in…
Bobby Liu of Milton Holdings International outlines the company’s evolution in the plastics and packaging industry and the specialized services it provides to clients in medtech and pharmaceuticals. What…
Laurence Frémy, director for APAC at Laboratoires Expanscience, discusses emerging skincare and dermatology trends in the region and her priorities for the affiliate. Having had the experience of opening…
Zuellig Pharma’s Andi Umbricht discusses the distributor’s deep commitment to Asia, the adoption of new technologies, and emerging trends within the Hong Kong and Asian distribution markets. Zuellig Pharma has…
Frederic Charles, CEO of Pierre Fabre Hong Kong and Macau, outlines brand perceptions of Pierre Fabre’s dermatological products in Hong Kong, e-commerce, and other emerging skincare trends in Asia. …
Benjamin Chan of MediConcepts – a Hong Kong-based medtech CDMO – outlines the potential impact of the Greater Bay Area Initiative on Hong Kong medtech, and the key factors behind…
Gwenael Meneux of AstraZeneca Hong Kong and Macau gives his initial impression of the HK market, outlines his unusual career trajectory and the new innovations AZ is looking to bring…
Andy A. Liu, CEO of CW Data Technologies, a joint venture between WuXi AppTec and China Electronics Data Corporation at the intersection of Big Data and healthcare, discusses emerging trends…
George Kwan, managing director of Hoya Lens, one of the first contact lens manufacturers in Hong Kong, introduces recent new innovation introduced to the market, public sector collaboration, and future…
Wolfgang Niedermark of GIC in Hong Kong, part of the AHK network of German Chambers of Commerce worldwide assesses the business relationship between Germany and Asia and how Hong Kong…
See our Cookie Privacy Policy Here
